According to the limited number of studies, further investigations with larger sample size and other sites that may be concerned with epigenetic regulation of NIS expression are required to elucidate the role of these mechanisms in the progression of thyroid nodules, leading to finding novel diagnostic biomarkers and improving the effectiveness of therapies. The gene discussed is SLC5A5; the disease is thyroid nodule.